Skip to article
Astra

Maternal-Fetal Medicine

Placental Abruption

Placental abruption is a clinical diagnosis requiring immediate assessment of maternal hemodynamics, coagulation, and fetal status. Vaginal blood loss may substantially underestimate severity; management prioritizes resuscitation, early recognition of consumptive coagulopathy, and delivery based on maternal and fetal condition.

Clinical question: How should suspected placental abruption be evaluated, stabilized, and managed according to maternal condition, fetal status, and gestational age?

Emergency recognition

When to suspect placental abruption

Treat suspected abruption as an obstetric hemorrhage and fetal-risk emergency until stability is established.

Placental abruption is premature placental separation before delivery and occurs in approximately 0.6% to 1.2% of pregnancies. Presentation ranges from recurrent light bleeding in chronic abruption to concealed hemorrhage, uterine hypertonus, fetal hypoxia, maternal shock, and DIC. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and Management

Suspect abruption with new vaginal bleeding plus abdominal or back pain, uterine tenderness or hypertonus, frequent contractions/tachysystole, decreased fetal movement, nonreassuring fetal heart rate (FHR) findings, or trauma. Absence of vaginal bleeding does not exclude abruption because bleeding may be concealed. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental Abruption - StatPearls - NCBI BookshelfPubMedPlacental abruption

Risk is increased by prior abruption, chronic hypertension, preeclampsia, cigarette smoking, cocaine or other illicit drug exposure, PPROM, chorioamnionitis, fetal growth restriction, multifetal gestation, polyhydramnios or sudden uterine decompression, and abdominal trauma. Chronic hypertension confers a 3- to 4-fold higher risk and preeclampsia a 4- to 6-fold higher risk in the cited review. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and Management

Diagnosis

Diagnostic approach and limits of testing

No laboratory, imaging, or fetal-monitoring result independently confirms or excludes abruption.

Diagnosis integrates presentation, examination, fetal assessment, exclusion of placenta previa and other causes of antepartum bleeding, and postpartum placental findings when available. Do not delay resuscitation or indicated delivery to obtain imaging. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental Abruption - StatPearls - NCBI BookshelfPubMedPlacental abruption

Perform sterile speculum examination to evaluate bleeding and cervical source. If placental location is unknown, defer digital cervical examination until ultrasound has excluded placenta previa. PubMedPlacental Abruption - StatPearls - NCBI Bookshelf

Ultrasound is useful to determine placental location and may identify retroplacental, marginal, subchorionic, preplacental, or intraplacental collections. However, acute hemorrhage can be isoechoic to placenta. In one cited study, ultrasound sensitivity was 57.0% and negative predictive value 14.0%; another review reports high specificity but poor sensitivity. Thus, a negative scan must not provide reassurance when the clinical syndrome suggests abruption. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental abruption

Features that support severity assessment in suspected placental abruption. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental Abruption - StatPearls - NCBI BookshelfPubMedPlacental abruption
DomainHigh-concern findingsClinical consequence
Maternal statusHypotension, tachycardia, oliguria, altered mental status, severe persistent pain, or hypertonic uterus. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental abruptionEscalate resuscitation, prepare blood products, and expedite delivery when maternal instability is present. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental abruption
Fetal assessmentTerminal bradycardia, absent variability, recurrent decelerations, sinusoidal pattern, or fetal demise. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental Abruption - StatPearls - NCBI BookshelfSevere compromise in a viable fetus generally requires emergent delivery unless vaginal birth is imminent. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental abruption
CoagulationFalling platelets, prolonged PT/aPTT, or low fibrinogen. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementSuggests consumptive coagulopathy; guide component replacement and anesthesia/delivery planning. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental abruption
UltrasoundRetroplacental or other placental blood collection. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementSupports the diagnosis, but a normal study does not exclude abruption. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental Abruption - StatPearls - NCBI Bookshelf

Maternal stabilization

Immediate management of suspected acute abruption

Resuscitation and delivery planning proceed in parallel.

Place the patient in a monitored obstetric setting, establish at least two large-bore IV lines, begin crystalloid resuscitation as needed, obtain blood samples and crossmatched blood, and activate obstetric anesthesia, neonatal, blood-bank, and operating-room resources early when hemorrhage or fetal compromise is suspected. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental abruption

The amount of external bleeding should not determine urgency. Maternal status, fetal status, ongoing bleeding, uterine tone, and laboratory trajectory should drive escalation. Severe hemorrhage, maternal cardiovascular instability, or both mandate immediate delivery regardless of gestational age or neonatal resources. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental abruption

At near-term and term gestations, acute abruption is generally managed with maternal stabilization followed by delivery. Intrauterine maneuvers may have limited benefit in acute severe abruption and must not delay delivery for persistent category III FHR patterns or maternal deterioration. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and Management

Hemostatic resuscitation

Hemorrhage and DIC management

Abruption can cause rapid consumption of fibrinogen, platelets, and clotting factors.

Abruption is described as the most common cause of DIC in pregnancy. The classic pattern is thrombocytopenia, prolonged PT/aPTT, and hypofibrinogenemia, although fibrinogen may initially be normal or only mildly reduced because it is an acute-phase reactant in pregnancy. Early hypofibrinogenemia is particularly concerning in major obstetric hemorrhage. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and Management

Give packed red blood cells according to active blood loss, hemodynamics, expected ongoing hemorrhage, and time to delivery rather than a static hemoglobin threshold in active bleeding. Fresh frozen plasma is appropriate for multiple acquired factor deficiencies, including DIC or massive transfusion. Cryoprecipitate provides concentrated fibrinogen for acquired hypofibrinogenemia. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and Management

In the cited near-term and term review, cryoprecipitate was recommended to maintain fibrinogen above 50 to 100 mg/dL and platelets above 50,000/mL in active bleeding. A more recent anesthesia review emphasizes that fibrinogen below 2 g/L is inadequate for effective coagulation and predicts severe hemorrhage; institutional obstetric hemorrhage protocols should govern target selection and product dosing. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental abruption

Blood-component selection in abruption-associated hemorrhage. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental abruption
ProblemSupportive component strategyMonitoring priority
Ongoing major blood loss or impaired oxygen deliveryPRBC transfusion guided by clinical status, active/anticipated bleeding, and time to delivery. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementHemodynamics, estimated and concealed loss, hemoglobin trend, perfusion. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and Management
Multiple factor deficiency or DICFFP for acquired multiple coagulation-factor deficiency; do not use solely as volume replacement. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPT/aPTT, fibrinogen, bleeding, and viscoelastic testing if available. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and Management
Acquired hypofibrinogenemiaCryoprecipitate is a mainstay; fibrinogen concentrate is discussed in observational evidence but preemptive randomized strategies did not reduce transfusion. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementFibrinogen and/or viscoelastic clot-strength measures. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental abruption
Thrombocytopenia with active bleeding or procedurePlatelet transfusion; cited review uses a goal above 50,000/mL in active bleeding. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPlatelet count, surgical bleeding, and overall coagulopathy. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and Management

Obstetric management

Delivery route and timing

The decision is driven by maternal stability, fetal status, labor progress, and the risks of operative bleeding.

For acute abruption, severe hemorrhage or maternal instability requires immediate delivery. A viable fetus with severe FHR compromise generally requires emergent cesarean delivery unless vaginal delivery is imminent. With reassuring fetal status and maternal stability, delivery route can be individualized; vaginal birth may be appropriate when labor is progressing and can be safely completed. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental abruption

If fetal death has occurred, vaginal delivery is preferred in most cases because cesarean delivery increases surgical hemorrhage risk in a setting predisposed to DIC and may add future uterine scar morbidity. Cesarean delivery may still be required for maternal indications, contraindication to vaginal delivery, or individualized concern for uterine rupture. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental abruption

Chronic abruption has limited evidence for optimal timing. Following inpatient observation, selected stable preterm patients may be managed outpatient if they can comply with surveillance. The cited review recommends once- or twice-weekly antenatal surveillance from diagnosis, serial growth assessment, and Dopplers when fetal growth restriction or fetal anemia is suspected. Delivery during 36 to 37 weeks is presented as expert opinion, with earlier delivery for ongoing bleeding, FHR abnormalities, oligohydramnios, or growth restriction. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and Management

Delivery decisions in placental abruption. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental abruption
Clinical scenarioRecommended direction
Severe hemorrhage or maternal cardiovascular instabilityImmediate delivery after/while initiating maternal resuscitation, regardless of gestational age. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental abruption
Viable fetus with severe FHR compromiseEmergent cesarean delivery unless vaginal birth is imminent. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental abruption
Maternal and fetal stability with progressing laborVaginal delivery may be reasonable with continuous reassessment and ability to proceed to cesarean delivery if status changes. PubMedPlacental abruption
Fetal demiseVaginal delivery is generally preferred; individualize if maternal condition or obstetric factors require surgery. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental abruption
Stable chronic abruption before termObservation followed by individualized surveillance and planned delivery; limited evidence supports exact timing. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and Management

Periprocedural care

Anesthesia and post-delivery monitoring

Abruption-associated coagulopathy changes both anesthetic and postpartum risk.

Neuraxial anesthesia may be feasible in a normovolemic, cardiovascularly stable patient without clinically significant coagulopathy, but abruption can produce rapidly evolving coagulopathy. Coagulation assessment and correction are necessary before neuraxial catheter removal. General anesthesia is indicated with major hemorrhage or instability. PubMedPlacental abruption

After delivery, monitor closely for recurrent hemorrhage, uterine atony, persistent coagulopathy, renal injury, and complications of major transfusion. Patients with major hemorrhage or DIC may require higher-acuity postpartum monitoring or intensive care. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental abruption

Placental pathology can support retrospective diagnosis but cannot direct initial management. Placental examination may show an adherent retroplacental clot or decidual hemorrhage with placental indentation; acute and chronic cases can have nonspecific findings. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and Management

Counseling

Recurrence, outcomes, and future pregnancy planning

Abruption identifies both recurrence risk and longer-term vascular risk.

A history of abruption confers up to a 10-fold increased recurrence risk in a subsequent pregnancy; risk is reported as 25-fold higher after two prior affected pregnancies. In another cited review, recurrence is reported as 4% to 12%. Counseling should therefore include early prenatal risk assessment and attention to modifiable contributors, especially smoking, cocaine or other illicit drug use, and hypertension control. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental Abruption - StatPearls - NCBI Bookshelf

Maternal short-term risks include hemorrhagic shock, DIC, transfusion, hysterectomy, renal failure, ICU admission, and death. Perinatal risks include fetal hypoxia, stillbirth, preterm birth, and fetal growth restriction. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental Abruption - StatPearls - NCBI Bookshelf

A systematic review and meta-analysis cited in the near-term/term review found a 2.65-fold higher risk of combined cardiovascular and stroke mortality after abruption. This association supports communication of abruption history to longitudinal primary care and cardiovascular clinicians, while recognizing that causal pathways and optimal preventive interventions are not established by the cited literature. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and Management

Common questions

Can ultrasound rule out placental abruption?

No. Ultrasound can identify placental location and some hematomas, but acute blood may be isoechoic to placenta. A negative ultrasound does not exclude clinical or concealed abruption. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental Abruption - StatPearls - NCBI BookshelfPubMedPlacental abruption

What laboratory tests should be ordered immediately when abruption is suspected?

Order CBC with platelet count, PT, aPTT, fibrinogen, type and screen/crossmatch, and renal function. Repeat testing based on bleeding and clinical trajectory; initial hemoglobin may not reflect acute concealed blood loss. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental abruption

When is cesarean delivery indicated in placental abruption?

Emergent cesarean delivery is generally indicated for a viable fetus with severe persistent compromise unless vaginal delivery is imminent. Severe hemorrhage or maternal instability requires immediate delivery, with route determined by the fastest and safest maternal-fetal option. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental abruption

Is vaginal delivery appropriate after abruption-associated fetal demise?

Usually yes. Vaginal delivery is generally preferred because it avoids surgical bleeding risk in a patient prone to DIC; individualize for maternal instability, contraindications to vaginal birth, or concern for uterine rupture. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and ManagementPubMedPlacental abruption

How should chronic placental abruption be monitored?

Evidence is limited. After initial observation, selected stable patients may undergo outpatient management with serial growth assessment and once- or twice-weekly NST or biophysical profile from diagnosis; use Dopplers for concurrent growth restriction or suspected fetal anemia. PubMedPlacental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and Management

References

  1. - IIER - accessdata.fda.govwww.accessdata.fda.gov · www.accessdata.fda.gov
  2. Device Registration and Listing Module Systemwww.access.fda.gov · www.access.fda.gov
  3. Application - Product Code Builderwww.accessdata.fda.gov · www.accessdata.fda.gov
  4. Managing hepatic complications of pregnancybmjopengastro.bmj.com · bmjopengastro.bmj.com
  5. Cardiovascular Management in Pregnancy | Circulationwww.ahajournals.org · www.ahajournals.org
  6. Chronic Hypertension in Pregnancy | Circulationwww.ahajournals.org · www.ahajournals.org
  7. Soluble Endoglin As a Marker for Preeclampsia, Its ...www.ahajournals.org · www.ahajournals.org
  8. Update on the Use of Antihypertensive Drugs in Pregnancywww.ahajournals.org · www.ahajournals.org
  9. advanced.onlinelibrary.wiley.comadvanced.onlinelibrary.wiley.com · advanced.onlinelibrary.wiley.com
  10. Solutio Placentae - an overviewwww.sciencedirect.com · www.sciencedirect.com
  11. Abruptio placentae: Clinical management in nonacute caseswww.sciencedirect.com · www.sciencedirect.com
  12. Placental abruption leading to disseminated intravascular ...www.sciencedirect.com · www.sciencedirect.com
  13. Maternal outcomes of placental abruption with intrauterine ...obgyn.onlinelibrary.wiley.com · obgyn.onlinelibrary.wiley.com
  14. Etiology, clinical manifestations, and prediction of placental ...obgyn.onlinelibrary.wiley.com · obgyn.onlinelibrary.wiley.com
  15. Risk Factor Profiles of Placental Abruption in First and Second Pregnancies: Heterogeneous Etiologieswww.sciencedirect.com · www.sciencedirect.com
  16. Women with a history of placental abruption: when in a ...obgyn.onlinelibrary.wiley.com · obgyn.onlinelibrary.wiley.com
  17. The Risk Factors for Placental Abruption in Preeclamptic ...obgyn.onlinelibrary.wiley.com · obgyn.onlinelibrary.wiley.com
  18. Placental abruption leading to disseminated intravascular coagulation: a clinical case and short review - PMCpmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  19. Placental Abruption at Near-Term and Term Gestations: Pathophysiology, Epidemiology, Diagnosis, and Managementpmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  20. Placental Abruption - StatPearls - NCBI Bookshelfwww.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
  21. Placental abruptionpmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  22. Interventions for treating placental abruption - PMCpmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  23. Placenta Previa - StatPearls - NCBI Bookshelfwww.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov
  24. PubMed - NIHpubmed.ncbi.nlm.nih.gov · pubmed.ncbi.nlm.nih.gov